Young W F, Abboud C F, Laws E R, Van Loon J A, Weinshilboum R M
J Clin Endocrinol Metab. 1984 Dec;59(6):1207-10. doi: 10.1210/jcem-59-6-1207.
Dopamine is metabolized by oxidative deamination catalyzed by monoamine oxidase, O-methylation catalyzed by catechol-O-methyltransferase, and sulfate conjugation catalyzed by phenol sulfotransferase. This study was performed to determine whether platelet monoamine oxidase, red blood cell catechol-O-methyltransferase and platelet phenol sulfotransferase enzymatic activities in patients with prolactinomas were quantitatively different from the same enzyme activities in blood samples from normal subjects. The mean enzyme activities in blood samples from 22 women with histologically proven prolactinomas were compared to the mean enzyme activities in blood samples from 32 normal women. The blood levels of these 3 enzymatic activities were not significantly different between the two groups (P greater than 0.4). If the regulation of these catecholamine-metabolizing enzyme activities in blood elements reflects the regulation of the enzymes in the hypothalamic-hypophyseal region, these results suggest that a defect in the regulation of dopamine-metabolizing enzymes is not associated with the pathogenesis of prolactinomas.
多巴胺通过单胺氧化酶催化的氧化脱氨、儿茶酚-O-甲基转移酶催化的O-甲基化以及酚磺基转移酶催化的硫酸结合作用进行代谢。本研究旨在确定泌乳素瘤患者血小板单胺氧化酶、红细胞儿茶酚-O-甲基转移酶和血小板酚磺基转移酶的酶活性与正常受试者血样中相同酶活性在数量上是否存在差异。将22名经组织学证实患有泌乳素瘤的女性血样中的平均酶活性与32名正常女性血样中的平均酶活性进行比较。两组之间这三种酶活性的血药浓度无显著差异(P大于0.4)。如果血液成分中这些儿茶酚胺代谢酶活性的调节反映了下丘脑-垂体区域酶的调节,那么这些结果表明多巴胺代谢酶调节缺陷与泌乳素瘤的发病机制无关。